ARCHIVES

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

This article is from The Cancer Letter archive.

Vol. 32 No. 01 | January 13, 2006

Download PDF Visit The Full Archive

Related Articles

Cooperative Groups Cut In On $1 Million Head 7 Neck Projects

March 25, 1977

Researchers Discover Bacteria Common in Colon Cancer Tissue

October 28, 2011

Alvarez Named New President of The Society of Gynecologic Oncology; Society Restructures

April 13, 2012

Administration’s FY 1981 Budget Would Leave Gaps, Curtail Many Program, Without New Cuts

March 28, 1980

Also in this 12-page issue: Senate report endorses NCI’s 2015 goal.

July 22, 2005

NCI’s Hawk To Lead Prevention Division At M.D. Anderson.

November 16, 2007